Pitney Bowes Case Study
Font Size A A | Print Page

Case Study: Pitney Bowes

Lowering Cost Barriers to Treatment

Pitney Bowes uses an integrated approach to disease management:

Preliminary results after 3 years (2002-2004) include the following:

  • The percentage of employees using fixed combination oral hypoglycemics increased from
    9% to 22%.
  • Test-strip usage rates increased from 28% to 55%.1
  • Total annual pharmacy costs per covered person showed a mild increase. But total pharmacy costs for employees with diabetes decreased by 7%.1
  • Suboptimal adherence to insulin therapy decreased by two thirds.1
  • Adherence rates increased, particularly among patients taking oral combination therapy.1
  • Total pharmacy costs for employees with diabetes decreased by 7%.1
  • Emergency room visits for employees with diabetes decreased by 26%. 1
  • Short-term disability days for employees with diabetes were reduced by approximately 50%.2
  • Direct healthcare costs for employees with diabetes decreased by 6%.1
  • Hospital admissions for employees with asthma were reduced by 38%.2

Pitney Bowes incorporated value-based health management for diabetes and asthma that resulted in better employee health management and decreased healthcare costs. enlarge chart

References:

  1. Mahoney JJ. Reducing patient drug acquisition costs can lower diabetes health claims. Am J Manag Care. 2005;11:S170-S176.
  2. Mahoney JJ. Role of employer and health plan in disease management. Presentation to National Business Coalition on Health. January 19, 2006.